M3 Research Center is a state-of-the-art international research institute including several core facilities. It offers regular lecture series and a positive, vivid, and inspiring environment. The goal of our group is to identify new vulnerabilities of tumour cells that can be exploited therapeutically. We are particularly interested in combining new treatment approaches with existing therapies to enhance anti-cancer effects. One focus of our group lies in the characterization of alternative splicing in liver cancer.
- a 3-year doctoral work contract and additional funding if needed
- a vibrant research environment
- an efficient supervision and mentoring program
- ability to gain knowledge in novel technologies and soft skills
- an excellent recent university degree: MSc/MRes (also candidates about to obtain such a degree are welcome to apply) or equivalent
- basic understanding of molecular and cell biology techniques
- experience in cancer or prior work with animals would be useful but is not essential
- high motivation and interest to join and work closely with other team member
- excellent communication skills in English
- interest and creativity to shape your thesis project
The applicant will work on the role of the spliceosome in hepatocellular carcinoma and cholangiocarcinoma. We use a wide range of cell biology and molecular biology methods including high throughput and high content microscopy, live cell imaging, proteomics, and RNA sequencing. Besides, we have established mouse models recapitulating the diseases.
Your full application should include a cover letter, CV, master’s degree, list of publications, and names and contacts of two scientific references.
severely handicapped persons with equal qualifications are given preferential consideration. Interview expenses are not covered. Please note the applicable vaccination regulations.